Literature DB >> 11254687

Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis.

A Elhabazi1, S Delaire, A Bensussan, L Boumsell, G Bismuth.   

Abstract

CD100 is the first semaphorin described in lymphoid tissues, where it has been shown to be associated with a serine kinase activity. Semaphorins are molecules involved in axon pathfinding during nerve development and act as repellent guidance cues. In the nervous system semaphorins exist as either membrane-bound or secreted forms. We report here a spontaneous processing of membrane CD100, suggesting that it is also produced as a diffusable semaphorin from lymphoid cells. Monomeric and homodimeric forms of CD100 are expressed by T lymphocytes and CD100-transfected fibroblasts. We demonstrate that CD100 is released through a proteolytic process blocked by metalloprotease inhibitors. In T cells, only soluble CD100 dimers are produced, suggesting that CD100 dimerization is required for proteolysis. In agreement, we observe that increasing membrane dimers strongly favors shedding of the molecule. By expressing a CD100 molecule mutated at cysteine 674 into a COS cell system, we additionally demonstrate that this particular residue in the extracellular domain of the molecule is required for dimerization. Finally, we show that staurosporine, a serine kinase inhibitor, enhances the membrane cleavage of CD100. Together these results demonstrate that membrane CD100 is cleaved by a metalloprotease-dependent process, which is probably regulated by phosphorylation. Mainly, these findings shed light on a possible function for the semaphorin region of CD100 as a long range guidance cue in the immune system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254687     DOI: 10.4049/jimmunol.166.7.4341

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

Review 1.  Semaphorins as signals for cell repulsion and invasion.

Authors:  Yoshio Goshima; Takaaki Ito; Yukio Sasaki; Fumio Nakamura
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 2.  Neuronal migration and molecular conservation with leukocyte chemotaxis.

Authors:  Yi Rao; Kit Wong; Michael Ward; Claudia Jurgensen; Jane Y Wu
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

3.  Dynamics of the skeletal muscle secretome during myoblast differentiation.

Authors:  Jeanette Henningsen; Kristoffer T G Rigbolt; Blagoy Blagoev; Bente Klarlund Pedersen; Irina Kratchmarova
Journal:  Mol Cell Proteomics       Date:  2010-07-14       Impact factor: 5.911

4.  Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis.

Authors:  John R Basile; Rogerio M Castilho; Vanessa P Williams; J Silvio Gutkind
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

Review 5.  Semaphorins: a new class of immunoregulatory molecules.

Authors:  Noriko Takegahara; Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

6.  An RNAi-based approach identifies molecules required for glutamatergic and GABAergic synapse development.

Authors:  Suzanne Paradis; Dana B Harrar; Yingxi Lin; Alex C Koon; Jessica L Hauser; Eric C Griffith; Li Zhu; Lawrence F Brass; Chinfei Chen; Michael E Greenberg
Journal:  Neuron       Date:  2007-01-18       Impact factor: 17.173

7.  Antitumor Effects of Anti-Semaphorin 4D Antibody Unravel a Novel Proinvasive Mechanism of Vascular-Targeting Agents.

Authors:  Iratxe Zuazo-Gaztelu; Marta Pàez-Ribes; Patricia Carrasco; Laura Martín; Adriana Soler; Mar Martínez-Lozano; Roser Pons; Judith Llena; Luis Palomero; Mariona Graupera; Oriol Casanovas
Journal:  Cancer Res       Date:  2019-06-25       Impact factor: 12.701

Review 8.  The evolving role of semaphorins and plexins in the immune system: Plexin-A1 regulation of dendritic cell function.

Authors:  Brian P O'Connor; Jenny P-Y Ting
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

9.  Enhanced potency of the metalloprotease inhibitor TAPI-2 by multivalent display.

Authors:  Aram J Raissi; Frank A Scangarello; Kaitlin R Hulce; Jason K Pontrello; Suzanne Paradis
Journal:  Bioorg Med Chem Lett       Date:  2014-02-14       Impact factor: 2.823

10.  PKC induces release of a functional ectodomain of the guidance cue semaphorin6A.

Authors:  Riley M St Clair; Caroline M Dumas; Kori S Williams; Matthew T Goldstein; Elizabeth A Stant; Alicia M Ebert; Bryan A Ballif
Journal:  FEBS Lett       Date:  2019-08-16       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.